B cells in multiple sclerosis

被引:12
作者
Burgoon, MP
Gilden, DH
Owens, GP
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Denver, CO 80262 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2004年 / 9卷
关键词
multiple sclerosis; MS; B cells; antibodies; oligoclonal bands; review; CNS; central nervious system; neurologic disease;
D O I
10.2741/1278
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The most common laboratory abnormality in multiple sclerosis (MS) is an increased amount of cerebrospinal fluid IgG and the presence of oligoclonal bands. Despite studies of the humoral response that suggest the involvement of an infectious agent or autoantigen in disease, the major targets of the oligoclonal response are still unknown. Identification of these targets will reveal valuable insights into the cause and pathogenesis of MS and is likely to lead to effective treatment.
引用
收藏
页码:786 / 796
页数:11
相关论文
共 129 条
[1]  
Agius MA, 1999, ACTA NEUROL SCAND, V100, P139
[2]   Tissue distribution and variant characterization of human herpesvirus (HHV)-6: Increased prevalence of HHV-6A in patients with multiple sclerosis [J].
Akhyani, N ;
Berti, R ;
Brennan, MB ;
Soldan, SS ;
Eaton, JM ;
McFarland, HF ;
Jacobson, S .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1321-1325
[3]   Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis [J].
Andersson, M ;
Yu, M ;
Söderström, M ;
Weerth, S ;
Baig, S ;
Linington, C ;
Solders, G ;
Link, H .
EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (03) :243-251
[4]  
[Anonymous], 1998, VIRAL INFECT NERVOUS
[5]  
Archelos JJ, 2000, ANN NEUROL, V47, P694, DOI 10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.3.CO
[6]  
2-N
[7]   OLIGODENDROCYTE-SPECIFIC EXPRESSION AND AUTOANTIGENICITY OF TRANSALDOLASE IN MULTIPLE-SCLEROSIS [J].
BANKI, K ;
COLOMBO, E ;
SIA, F ;
HALLADAY, D ;
MATTSON, DH ;
TATUM, AH ;
MASSA, PT ;
PHILLIPS, PE ;
PERL, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1649-1663
[8]  
Baranzini SE, 1999, J IMMUNOL, V163, P5133
[9]   Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [J].
Berger, T ;
Rubner, P ;
Schautzer, F ;
Egg, R ;
Ulmer, H ;
Mayringer, I ;
Dilitz, E ;
Deisenhammer, F ;
Reindl, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :139-145
[10]  
BERNARD CCA, 1975, J IMMUNOL, V114, P1537